ultherapy_hero
Home  |  Our Brands
Asset 1

Ultherapy®

Ultherapy® continues to stand alone as the only non-invasive skin lifting and tightening treatment with unique micro-focused ultrasound technology and real-time visualization (MFU-V).1,5
This non-invasive procedure uses microfocused ultrasound to trigger aggressive collagen synthesis, treating the same deep tissue planes as a modern facelift.1,9
Ultrasound visualization—employed during planning and energy application—makes the Ultherapy® treatment uniquely precise and customizable.1,5

Results for up to one year

Ultherapy® precisely targets dermal and subcutaneous tissues to create thermal coagulation points (TCPs), heating tissues to the optimal temperature for collagen contraction and denaturation. As part of the body’s wound healing response, long-term collagen remodeling delivers a gradual, natural-looking lift. Results can last a year or more.1-9

Ultherapy is the only FDA-cleared noninvasive lift effective for women, men and suitable for all skintypes and is certified in the EU as a medical device class II.5,10-12

oblique-with-amplify-screen-300dpi

Subscribe

Follow the latest aesthetic medicine trends and Merz’s latest updates.

Fabi SG, Joseph J, Sevi J, Green JB, Peterson JD. Optimizing patient outcomes by customizing treatment with microfocused ultrasound with visualization: gold standard consensus guidelines from an expert panel. J Drugs Dermatol. 2019;18(5):426-432.
Fabi SG, Massaki A, Eimpunth S, Pogoda J, Goldman MP. Evaluation of microfocused ultrasound with visualization for lifting, tightening, and wrinkle reduction of the décolletage. J Am Acad Dermatol. 2013;69(6):965-971.
Werschler WP, Werschler PS. Long-term efficacy of micro-focused ultrasound with visualization for lifting and tightening lax facial and neck skin using a customized vectoring treatment method. J Clin Aesthet Dermatol. 2016;9(2):27-33.
Ulthera release: Ultherapy® décolletage treatment now FDA-cleared. BioSpace website. https://www.biospace.com/article/releases/ulthera-release-ultherapy-and-0174-d%C3%A9colletage-treatment-now-fda-cleared-/. Accessed January 30, 2020.
Ulthera Instructions for Use.
Whitney ZB, Zito PM. Anatomy, skin, superficial musculoaponeurotic system (SMAS) fascia. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2019. https://www.ncbi.nlm.nih.gov/books/NBK519014/. Updated October 27, 2018. Accessed January 30, 2020.
Fabi SG. Noninvasive skin tightening: focus on new ultrasound techniques. Clin Cosmet Investig Dermatol. 2015;8:47-52.
Data on file. MOA.
Dobke MK, Hitchcock T, Misell L, Sasaki GH. Tissue restructuring by energy-based surgical tools. Clin Plast Surg. 2012;39(4):399-408
Ulthera release: Ultherapy décolletage treatment now FDA-cleared. BioSpace website. https://www.biospace.com/article/releases/ulthera-release-ultherapy-and-0174-d%C3%A9colletage-treatmentnow-fda-cleared-/. Accessed February 3, 2020.
Baumann L and Zelickson B. Evaluation of Micro-Focused Ultrasound for Lifting and Tightening Neck Laxity. J Drugs Dermatol. 2016;15(5):607-614.
Sevi, J. See. Plan. Treat.: Protocol Brief & Practice Case Study. 2019; 13.
The non-invasive Ultherapy® procedure is U.S. FDA-cleared to lift skin on the neck, on the eyebrow and under the chin as well as to improve lines and wrinkles on the décolleté. The CE Mark (CE0344) indications for use for the Ulthera® System include non-invasive dermatological sculpting and lifting of the dermis on the upper face, lower face, neck and décolleté. Reported adverse events from post-marketing surveillance are available in the Instructions for Use (IFU).